PROCEDURES AND COMPOSITIONS OF TREATMENT OF NEOVASCULARIZATION AND EYE NERVOUS INJURIES.

摘要

Use of an alpha receptor agonist for the manufacture of a medicament for use in a procedure for the reduction or elimination of a decrease in neurosensory retinal function after laser treatment of choroidal neovascularization (CNV), while maintaining the effect Therapeutic vascular occlusion of said therapy, the procedure comprising the steps: a) administration to a mammal having a CNV of a therapeutically effective amount of said medicament containing an alpha receptor agonist, wherein said neuroprotector is selected from the group constituted by an alpha 2B selective agonist, alpha 2C selective agonist, clonidine and para-aminoclonidine; b) subjecting said mammal to laser irradiation of the CNV retinal locus; wherein the amount of neurosensory retinal function after stages a) and b) is greater than when said mammal is subjected to stage b) without stage a).